FDA Approves Treatment for Moderate-to-Severe Chronic Hand Eczema
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
Concerns about skin flap viability have long kept many surgeons from combining these procedures. A new case series takes a closer look at whether that caution is still warranted.